Elasmogen is a privately held drug discovery and development, biopharmaceutical company located in the thriving biologics cluster now established for over 15 years in Aberdeen, Scotland.  Elasmogen Ltd spun-out of the University of Aberdeen and the Scottish Biologics Facility in February 2016.

deepbridge-logoinnovate-uk-logoSIB-logo

Elasmogen Ltd is backed by Deepbridge Capital LLP, the Scottish Investment Bank, Innovate UK and through access partnerships to its ground-breaking soloMER platform.